Early Access — free while we kick the tires
EdgarHawk

NSRX Nasus Pharma Ltd Insider Trading

Latest: CEO Bought $31K of Shares · Mar 2026
2 filings analyzed · Latest 2026-04-22
Insider buys
2
Insider sells
0
Unique insiders
1
Direction
Net buying
April 2026
2026-04-22
medium
Teleman Dan Benjamin Buy
Chief Executive Officer
2,900 shares
$10,904
@ $3.76
Significance 5/10

CEO Teleman bought 2,900 shares of NSRX at $3.76 on 2026-04-22, second buy in one month as stock recovered +55.6% in 30 days from 57.5% drawdown.

Teleman Dan Benjamin, Chief Executive Officer, purchased 2,900 shares at $3.76, bringing his total holdings to 156,991 shares (+1.9% from prior level). This marks his second open-market buy at NSRX within 22 days, following a March 31 purchase. The timing coincides with sharp price recovery: the stock is up 55.6% over the past 30 days but remains down 41.3% over 90 days and 57.5% below its 52-week high of $9.15. The CEO's repeated purchasing during this volatile period warrants attention to company fundamentals and any material developments driving the recent rally. At the current $3.89 price, the stock has already appreciated modestly from his transaction price, though its long-term trend remains challenged.

2026-04-01
high
Teleman Dan Benjamin Buy
Chief Executive Officer
15,000 shares
$30,600
@ $2.04
Significance 6/10

CEO Teleman buys 15,000 shares of NSRX at $2.04 amid -72.1% decline from 52-week high

Teleman Dan Benjamin, Chief Executive Officer, purchased 15,000 shares at $2.04 on 2026-03-31, expanding his holdings by 240.2% to 21,246 shares total. The transaction occurs in a context of material stock deterioration: NSRX is trading at $2.55, representing -72.1% from its 52-week high of $9.15 and -44.3% over the last 30 days. The CEO's purchase of a substantial absolute quantity—and tripling of his personal stake—stands out against this backdrop of sharp share price contraction. Without a track record or discretionary-trade FLAGS, the acquisition marks a direct personal capital commitment by the company's top executive at depressed price levels.

Get alerts for NSRX

Add NSRX to your watchlist and we'll email you when an insider files a Form 4 — with our AI's significance score and a plain-English read of what it means.

Sign up — free during early access